Brief Report: HLA–DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis

Arthritis and Rheumatology

Volumn 68, Issue 11, 2016, Pages 2772-2777

  Stevens, Anne M ^a   Kanaan, Sami B ^b   Torok, Kathryn S ^c   Medsger, Thomas A ^d   Mayes, Maureen D ^e   Reveille, John D ^e   Klein Gitelman, Marisa ^f   Reed, Ann M ^g   Lee, Tzielan ^h   Li, Suzanne C ⁱ   Henstorf, Gretchen ^j   Luu, Christine ^b   Aydelotte, Tessa ^b   Lee Nelson, J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^j SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; DNA TOPOISOMERASE I ANTIBODY; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; UNCLASSIFIED DRUG; DNA TOPOISOMERASE; HLA DQ ANTIGEN; HLA-DQA1 ANTIGEN; HLA-DQB1 ANTIGEN; JUVENILE-ONSET SCLERODERMA;

ALLELE; ARTICLE; CAUCASIAN; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HLA TYPING; HUMAN; JUVENILE ONSET SYSTEMIC SCLEROSIS; MAJOR CLINICAL STUDY; MALE; ODDS RATIO; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMIC SCLEROSIS; ADOLESCENT; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LOCALIZED SCLERODERMA; PHENOTYPE; PRESCHOOL CHILD; PROTECTION;

ADOLESCENT; ALLELES; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA TOPOISOMERASES, TYPE I; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ALPHA-CHAINS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; ODDS RATIO; PHENOTYPE; PROTECTIVE FACTORS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC;

EID: 84992643598     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39765     Document Type: Article

References (20)

1. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003;48:1956–63.
2. Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet 2014;94:47–61.
3. Torok KS. Pediatric scleroderma: systemic or localized forms. Pediatr Clin North Am 2012;59:381–405.
4. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A, et al. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006;54:3971–8.
5. Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 2006;33:1004–13.
6. Foeldvari I, Nihtyanova SI, Wierk A, Denton CP. Characteristics of patients with juvenile-onset systemic sclerosis in an adult single-center cohort. J Rheumatol 2010;37:2422–6.
7. Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, et al. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology (Oxford) 2007;46:1786–91.
8. Loubiere LS, Lambert NC, Madeleine MM, Porter AJ, Mullarkey ME, Pang JM, et al. HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women. Rheumatology (Oxford) 2005;44:318–22.
9. Jacobe H, Ahn C, Arnett FC, Reveille JD. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort. Arthritis Rheumatol 2014;66:3170–7.
10. Foeldvari I, Tyndall A, Zulian F, Muller-Ladner U, Czirjak L, Denton C, et al. Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database. Rheumatology (Oxford) 2012;51:1832–7.
11. Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010;69:822–7.
12. Simeon CP, Fonollosa V, Tolosa C, Palou E, Selva A, Solans R, et al. Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol 2009;36:2733–6.
13. Vlachoyiannopoulos PG, Dafni UG, Pakas I, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Moutsopoulos HM. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. Ann Rheum Dis 2000;59:359–67.
14. Morel PA, Chang HJ, Wilson JW, Conte C, Saidman SL, Bray JD, et al. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Hum Immunol 1994;40:101–10.
15. Lambert NC, Distler O, Muller-Ladner U, Tylee TS, Furst DE, Nelson JL. HLA–DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis Rheum 2000;43:2005–10.
16. Luderschmidt C, Scholz S, Mehlhaff E, Konig G, Albert E. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles. Arch Dermatol 1987;123:1188–91.
17. Azzouz DF, Rak JM, Fajardy I, Allanore Y, Tiev KP, Farge-Bancel D, et al. Comparing HLA shared epitopes in French Caucasian patients with scleroderma. PLoS One 2012;7.
18. Beretta L, Rueda B, Marchini M, Santaniello A, Simeon CP, Fonollosa V, et al. Analysis of class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology (Oxford) 2012;51:52–9.
19. Reveille JD, Durban E, MacLeod-St Clair MJ, Goldstein R, Moreda R, Altman RD, et al. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992;90:973–80.
20. He D, Wang J, Yi L, Guo X, Guo S, Guo G, et al. Association of the HLA-DRB1 with scleroderma in Chinese population. PLoS One 2014;9.